Interleukin-2 for prevention of graft-versus-host disease after haploidentical marrow transplantation.
Przepiorka
D
D
Section of Bone Marrow Transplantation, U.T.M.D. Anderson Cancer Center, Houston 77030.
Ippoliti
C
C
Koberda
J
J
Chan
K W
KW
Khouri
I F
IF
Fischer
H E
HE
Huh
Y O
YO
Escudier
S M
SM
Seong
D
D
Davis
M
M
D000293:Adolescent; D000328:Adult; D016026:Bone Marrow Transplantation / Q000276:immunology*; D002648:Child; D005260:Female; D006086:Graft vs Host Disease / Q000209:etiology / Q000517:prevention & control*; D006239:Haplotypes; D006801:Humans; D007376:Interleukin-2 / Q000627:therapeutic use*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000628:therapy; D008297:Male; D008875:Middle Aged; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000628:therapy
D007376:Interleukin-2